中信大锰(01091.HK)附属未参与信盛矿业(02133.HK)供股 持股将降至约23.99%
中信大锰(01091.HK)公布,集团之联营公司信盛矿业(02133.HK)建议透过四股供一股供股筹集约4,920万元,而目前集团全资附属中信大锰投资直接持有信盛矿业约29.99%的权益。
集团指,自去年下半年开始一直面临营运挑战。此外,最近新型冠状病毒性肺炎的爆发对宏观环境带来的不利影响为集团营运环境带来进一步的不确定性和挑战。因此,集团的重要战略之一是保存现金并最小化资本支出和投资,故中信大锰投资并未参与供股,因而在供股完成後,集团在信盛矿业中的持股比例将降至约23.99%。
然而,集团仍将是信盛矿业的最大单一股东,并将继续持股作为关联公司入账。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.